SILK ROAD MEDICAL INC (SILK)
US82710M1009 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 101.5M 34.97% | 138.6M 36.55% | 177.134M 27.80% | 203.98M 15.16% | 226.77M 11.17% | 249.32M 9.94% | 290.9M 16.68% | |
| EBITDA YoY % growth | -46.47M -10.35% | -49.87M -7.32% | -56.575M -13.44% | -37.291M 34.09% | -26.663M 28.50% | -18.054M 32.29% | N/A | |
| EBIT YoY % growth | -47.5M -10.72% | -52M -9.47% | -59.271M -13.98% | -60.11M -1.42% | -55.21M 8.15% | -50.85M 7.90% | -48.144M 5.32% | |
| Operating Margin | -46.80% | -37.52% | -33.46% | -29.47% | -24.35% | -20.40% | -16.55% | |
| EPS YoY % growth | -1.44 | -1.54 -6.94% | -1.44 6.49% | -1.49 -3.77% | -1.34 10.24% | -1.26 5.70% | -1.20 4.84% |
All data in USD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 -8.18% | -0.35 -5.09% | -0.39 -9.08% | -0.32 23.09% | -0.31 14.29% | -0.28 19.61% |
| Revenue Q2Q % growth | 50.249M 13.08% | 52.302M 10.65% | 53.087M 9.49% | 55.959M 9.21% | 55.521M 10.49% | 59.857M 14.44% |
| EBITDA Q2Q % growth | -15.83M -36.12% | -7.371M 36.87% | -10.941M 23.43% | -6.63M 58.27% | -6.63M 58.12% | -6.12M 16.97% |
| EBIT Q2Q % growth | -15.991M -16.98% | -14.121M 1.74% | -14.833M 0.68% | -12.534M 27.11% | -12.007M 24.91% | -11.612M 17.77% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.42 -20.00% | -0.38 | -0.04 | -9.60% |
| Q1 2024 Q2Q % growth | -0.36 16.28% | -0.41 | 0.05 | 12.31% |
| Q4 2023 Q2Q % growth | -0.33 2.94% | -0.43 | 0.10 | 23.20% |
| Q3 2023 Q2Q % growth | -0.33 -13.79% | -0.36 | 0.03 | 8.23% |
| Q2 2023 Q2Q % growth | -0.35 18.60% | -0.40 | 0.05 | 11.99% |
| Q1 2023 Q2Q % growth | -0.43 10.42% | -0.40 | -0.03 | -7.15% |
| Q4 2022 Q2Q % growth | -0.34 19.05% | -0.38 | 0.04 | 11.58% |
| Q3 2022 Q2Q % growth | -0.29 27.50% | -0.43 | 0.14 | 33.17% |
| Q2 2022 Q2Q % growth | -0.43 -38.71% | -0.47 | 0.04 | 8.39% |
| Q1 2022 Q2Q % growth | -0.48 -54.84% | -0.38 | -0.10 | -26.61% |
| Q4 2021 Q2Q % growth | -0.42 14.29% | -0.36 | -0.06 | -15.34% |
| Q3 2021 Q2Q % growth | -0.40 -29.03% | -0.31 | -0.09 | -30.28% |
| Q2 2021 Q2Q % growth | -0.31 3.13% | -0.37 | 0.06 | 16.81% |
| Q1 2021 Q2Q % growth | -0.31 3.13% | -0.40 | 0.09 | 22.27% |
| Q4 2020 Q2Q % growth | -0.49 -81.48% | -0.29 | -0.20 | -71.88% |
| Q3 2020 Q2Q % growth | -0.31 -19.23% | -0.29 | -0.02 | -6.58% |
| Q2 2020 Q2Q % growth | -0.32 23.81% | -0.38 | 0.06 | 14.89% |
| Q1 2020 Q2Q % growth | -0.32 98.41% | -0.32 | 0.00 | -1.20% |
| Q4 2019 Q2Q % growth | -0.27 | -0.27 | 0.00 | 0.74% |
| Q3 2019 Q2Q % growth | -0.26 | -0.28 | 0.02 | 5.59% |
| Q2 2019 Q2Q % growth | -0.42 | -0.28 | -0.14 | -51.11% |
| Q1 2019 Q2Q % growth | -20.12 | -0.32 | -19.80 | -6,129.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 51.242M 13.12% | 50.596M | 646K | 1.28% |
| Q1 2024 Q2Q % growth | 48.484M 20.81% | 45.569M | 2.915M | 6.40% |
| Q4 2023 Q2Q % growth | 47.27M 17.97% | 42.813M | 4.457M | 10.41% |
| Q3 2023 Q2Q % growth | 44.435M 18.91% | 45.435M | -1M | -2.20% |
| Q2 2023 Q2Q % growth | 45.298M 36.56% | 44.103M | 1.195M | 2.71% |
| Q1 2023 Q2Q % growth | 40.131M 43.22% | 41.504M | -1.373M | -3.31% |
| Q4 2022 Q2Q % growth | 40.07M 41.74% | 38.094M | 1.976M | 5.19% |
| Q3 2022 Q2Q % growth | 37.37M 51.30% | 34.308M | 3.062M | 8.93% |
| Q2 2022 Q2Q % growth | 33.17M 25.36% | 31.647M | 1.523M | 4.81% |
| Q1 2022 Q2Q % growth | 28.02M 27.07% | 27.64M | 380K | 1.37% |
| Q4 2021 Q2Q % growth | 28.27M 33.79% | 26.418M | 1.852M | 7.01% |
| Q3 2021 Q2Q % growth | 24.7M 23.07% | 26.756M | -2.056M | -7.68% |
| Q2 2021 Q2Q % growth | 26.46M 75.35% | 25.839M | 621K | 2.40% |
| Q1 2021 Q2Q % growth | 22.05M 16.48% | 21.722M | 328K | 1.51% |
| Q4 2020 Q2Q % growth | 21.13M 13.42% | 21.768M | -638K | -2.93% |
| Q3 2020 Q2Q % growth | 20.07M 17.85% | 19.983M | 87K | 0.44% |
| Q2 2020 Q2Q % growth | 15.09M 1.07% | 9.652M | 5.438M | 56.34% |
| Q1 2020 Q2Q % growth | 18.93M 48.24% | 17.673M | 1.257M | 7.11% |
| Q4 2019 Q2Q % growth | 18.63M 62.42% | 18.329M | 301K | 1.64% |
| Q3 2019 Q2Q % growth | 17.03M 77.21% | 16.221M | 809K | 4.99% |
| Q2 2019 Q2Q % growth | 14.93M 92.15% | 13.913M | 1.017M | 7.31% |
| Q1 2019 Q2Q % growth | 12.77M 123.64% | 12.431M | 339K | 2.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.92% | -2.69% | -2.45% |
| Revenue | 0% | 1.22% | 0.58% | 1.15% |